TWC
LYRA

TD Waterhouse Canada’s LYRA THERAPEUTICS INC LYRA Stock Holding History

TD Waterhouse Canada’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4
Closed -$1.07K – 1752
2022
Q2 		$1.07K Hold
4
– – ﹤0.01% 1613
2022
Q1 		$830 Hold
4
– – ﹤0.01% 1686
2021
Q4 		$870 Buy
+4
New +$1.28K ﹤0.01% 1660

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

TD Waterhouse Canada's LYRA Position: Q3 2022 in Review

TD Waterhouse Canada sold out of LYRA THERAPEUTICS INC (LYRA) in Q3 2022, closing a stake of 4 shares — an estimated $1.07K sold.

TD Waterhouse Canada first reported a position in LYRA in Q4 2021 and held it in 3 quarters. The position peaked at $1.07K in Q2 2022. 37 funds tracked by Wall St. Rank hold LYRA as of Q3 2022.

  • TD Waterhouse Canada reported no remaining LYRA THERAPEUTICS INC position as of Q3 2022 after selling out during the quarter.
  • TD Waterhouse Canada sold 4 LYRA THERAPEUTICS INC shares in Q3 2022, an estimated $1.07K.
  • TD Waterhouse Canada first reported a position in LYRA THERAPEUTICS INC in Q4 2021 and held it in 3 quarters.
  • TD Waterhouse Canada's LYRA THERAPEUTICS INC position peaked at $1.07K in Q2 2022.
  • 37 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q3 2022.

Based on TD Waterhouse Canada's 13F filing for Q3 2022, filed 13 Nov 2023.